Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8488)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2023 (publication date) through Mar 28, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Juneja D, Nasa P, Jain R, Singh O. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports. World J Diabetes 2023; 14(8): 1314-1322 [PMID: 37664476 DOI: 10.4239/wjd.v14.i8.1314] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Juneja D, Nasa P, Jain R, Singh O. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports. World J Diabetes 2023; 14(8): 1314-1322 [PMID: 37664476 DOI: 10.4239/wjd.v14.i8.1314] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i8/1314.htm |
| Number | Citing Articles |
| 1 |
Glenda Elaine Bilder, Patricia Brown-O’Hara. Drug Use in the Older Adult. 2025; : 45 doi: 10.1007/978-3-031-84831-5_3
|
| 2 |
Dimitra Stathi, Ketan K. Dhatariya, Omar G. Mustafa. Management of diabetes‐related hyperglycaemic emergencies in advanced chronic kidney disease: Review of the literature and recommendations. Diabetic Medicine 2025; 42(2) doi: 10.1111/dme.15405
|
| 3 |
Andreas Holstein, Jonas A. Linck, Johann Christoph Blaue, Rainer Högel, David J. F. Holstein. Successful renal replacement therapy of extreme ertugliflozin and alcohol induced euglycaemic ketoacidosis. Acta Diabetologica 2024; 62(3): 433 doi: 10.1007/s00592-024-02417-8
|
| 4 |
Eslam Abady, Panos I. Tamvakologos, Marina Ramzy Mourid, Salma Tamer Abdelrahman, Mayam Mohamed Aziz, Shree Rath, Lauren A. Carr, Mohammed Alsabri. A narrative review of the diabetic ketoacidosis and hyperosmolar hyperglycemic state overlap syndrome. International Journal of Emergency Medicine 2025; 18(1) doi: 10.1186/s12245-025-01078-w
|
| 5 |
Paul S. Pagel, Dustin Hang, Julie K. Freed, George J. Crystal. Advances in Cardiovascular Pharmacotherapy. IV. Sodium-Glucose Cotransporter Type 2 Inhibitors, Part 2: Mechanisms for Myocardial Protection, Adverse Effects, and Perioperative Implications. Journal of Cardiothoracic and Vascular Anesthesia 2025; 39(11): 3122 doi: 10.1053/j.jvca.2025.06.015
|
| 6 |
Rupak Chatterjee, Rajat K Goswami, Atanu Chandra, Shambo S Samajdar, Shatavisa Mukherjee, Nandini Chatterjee, Jyotirmoy Pal, Sarmishtha Mukhopadhyay. Euglycemic Diabetic Ketoacidosis in Patients on Sodium–Glucose Cotransporter-2 Inhibitors: A Preliminary Observation from Eastern India. Bengal Physician Journal 2025; 12(4): 184 doi: 10.5005/jp-journals-10070-8106
|
| 7 |
Elsayed Balbaa, Ahmed Farid Gadelmawla, Ahmed Ibrahim, AlMothana Manasrah, Ahmed Elbataa, Abdalhakim Shubietah, Mohamed S. Elgendy, Ahmed Sobhy, Ahmed Mansour, Ameer Awashra, Nourhan N. Elguindy, Mohammad Bazzazeh, Abdelhamid Ben‐Selma. Renal Protection at a Metabolic Cost: A Systematic Review and Meta‐Analysis of Perioperative Use of Sodium–Glucose Cotransporter 2 Inhibitors. Endocrinology, Diabetes & Metabolism 2026; 9(2) doi: 10.1002/edm2.70180
|
| 8 |
Lulu Chu, Zhenhua Xi, Runzhi Ma, Weiliang Shi, Guoshen Yu. Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report. BMC Neurology 2025; 25(1) doi: 10.1186/s12883-025-04027-5
|
| 9 |
Johannes Nienhaus, Theresa Tenge, Sophia Riesemann, Detlef Kindgen-Milles, Giovanna Lurati Buse, René MʼPembele, Sebastian Roth. Natrium-Glukose-Co-Transporter-2 (SGLT-2)-Hemmer in der perioperativen Medizin. Die Anaesthesiologie 2025; 74(10): 655 doi: 10.1007/s00101-025-01580-z
|
| 10 |
Jose Guillermo Cabanillas-López, Luis Ángel Rodriguez-Chávez, Melissa Ysabel Romero-Diaz, Christian Alberto Vargas-Machuca Carranza. Cetoacidosis euglucémica por empagliflozina: Reporte de un caso. Medicina Clínica Práctica 2026; 9(2): 100535 doi: 10.1016/j.mcpsp.2026.100535
|
| 11 |
Swapnil Khare, Mihail Zilbermint, Rajesh Garg, Viral N. Shah. Navigating the New Frontiers of Hyperglycemic Crisis Management: Unveiling the Latest American Diabetes Association Consensus Report. Endocrine Practice 2024; 30(9): 895 doi: 10.1016/j.eprac.2024.06.011
|
| 12 |
Japleen Kaur, Ashima Dogra, Anna Haymov. When Falls Reveal Acidosis: Unmasking Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor–Induced Euglycemic Diabetic Ketoacidosis. Cureus 2025; doi: 10.7759/cureus.95681
|
| 13 |
Teodora Mateoc, Andrei-Luca Dumitrascu, Corina Flangea, Daniela Puscasiu, Tania Vlad, Roxana Popescu, Cristina Marina, Daliborca-Cristina Vlad. SGLT2 Inhibitors: From Structure–Effect Relationship to Pharmacological Response. International Journal of Molecular Sciences 2025; 26(14): 6937 doi: 10.3390/ijms26146937
|
| 14 |
Caroline G. P. Roberts, Shaminie J. Athinarayanan, Robert E. Ratner, Guillermo E. Umpierrez. Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets. Diabetes, Obesity and Metabolism 2025; 27(5): 2531 doi: 10.1111/dom.16252
|
| 15 |
José Paz-Ibarra, Juan Eduardo Quiroz-Aldave, María del Carmen Durand-Vásquez, Luis Alberto Concepción-Urteaga, Rommy Díaz Quispe, Marcio José Concepción-Zavaleta. Primer caso reportado en Perú de cetoacidosis euglicémica por inhibidor del cotransportador de sodio glucosa tipo 2. Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo 2025; 18(1): e2677 doi: 10.35434/rcmhnaaa.2025.181.2677
|
| 16 |
Natalia G. Vallianou, Dimitris C. Kounatidis, Eleni V. Geladari, Angelos Evangelopoulos, Vasileios Kaldis, Theodora Stratigou, Apostolos A. Evangelopoulos, Irene Karampela, Maria Dalamaga. Climate Change, Air Pollution and the Global Obesity Syndemic: a Review of Current Evidence. Current Obesity Reports 2025; 14(1) doi: 10.1007/s13679-025-00671-7
|
| 17 |
Andrijana Koceva, Nika Aleksandra Kravos Tramšek. From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Journal of Personalized Medicine 2024; 14(7): 665 doi: 10.3390/jpm14070665
|
| 18 |
Hiroshi Bando, Michael Wood, Koji Ebe. Expanding Applications of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT-2i) with Attention to Euglycemic Ketoacidosis (Eka) for No Diabetic History. Diabetes Research: Open Access 2025; 6(1): 6 doi: 10.36502/2025/droa.6191
|
| 19 |
Rohini Garg, Nikhil Sood, Ojas Bansal, Abhinav Hoskote. Euglycemic Ketoacidosis Associated with SGLT-2 Inhibitors in Non-diabetic Patients—A Narrative Review. Journal of General Internal Medicine 2025; 40(2): 437 doi: 10.1007/s11606-024-09073-2
|
| 20 |
Mahesh Ramanan, Elif Ekinci. Oh's Intensive Care Manual. 2026; : 815 doi: 10.1016/B978-0-443-11611-7.00068-2
|
| 21 |
Alessandro Rossi, Chiara Simeoli, Rosario Pivonello, Mariacarolina Salerno, Carmen Rosano, Barbara Brunetti, Pietro Strisciuglio, Annamaria Colao, Giancarlo Parenti, Daniela Melis, Terry G.J. Derks. Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care. Reviews in Endocrine and Metabolic Disorders 2024; 25(4): 707 doi: 10.1007/s11154-024-09880-2
|
| 22 |
Selin Genc, Bahri Evren, Onur Selcuk Yigit, Ibrahim Sahin, Ramazan Dayanan, Aleksandra Klisic, Ayse Erturk, Filiz Mercantepe. Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors. Pharmaceuticals 2024; 17(11): 1553 doi: 10.3390/ph17111553
|
| 23 |
Nagendra K Singh, Akash Kumar Singh, Bijay Patni, Prabhat Agarwal, Manohar Kathige Nageshappa, Manish Kumar Prasad, Meena Chhabra, Noni G Singha, Minakshisundaram Shunmugavelu, Arvind Gupta, Sanjeev Phatak, Mangesh Tiwaskar, Sanjay Kalra, Manash Pratim Baruah, Thamburaj Anthuvan, Abhijit Pednekar, Ashish Prasad, Smriti Gadia. Consensus to Reduce Withdrawal and Improve Adherence with SGLT2i: Consensus TWO SGLT2i Adherence Group. Journal of The Association of Physicians of India 2025; 73(4): 75 doi: 10.59556/japi.73.0887
|
| 24 |
Afif Nakhleh, Areen Othman, Amin Masri, Moshe Zloczower, Sagit Zolotov, Naim Shehadeh. Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study. Biomedicines 2023; 11(10): 2689 doi: 10.3390/biomedicines11102689
|
| 25 |
Paul A. Stewart, Claire C. Nestor, Cillian Clancy, Michael G. Irwin. The peri‐operative implications of sodium‐glucose co‐transporter 2 inhibitors: a narrative review. Anaesthesia 2025; 80(1): 85 doi: 10.1111/anae.16461
|